Source: Cision

Faron received $32.2M in Post-IPO Equity Funding

Read full article »

Faron's Competitors | Faron's News | Faron's Financials

Followers on Owler

Annual Revenue

$100K-5.0M

Employees

25-100

Founder & CEO

Juho Jalkanen

CEO Approval Rating

90/100

Faron is a Finland-based clinical-stage biopharmaceutical company that researches and develops novel immunotherapies for the treatment of ARDS and cancer.